Market Overview:
The global nanoparticles in biotechnology and pharmaceuticals market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth of this market can be attributed to the increasing demand for nanoparticles in biotechnology and pharmaceutical applications. Nanoparticles are used in various applications such as drug delivery, diagnostics, biosensors, tissue engineering, and others. They offer several advantages over traditional particles including high surface area-to-volume ratio, tunable size and shape, controlled release of drugs or other molecules, and others. These advantages are driving the demand for nanoparticles in various end-use industries such as biotechnology and pharmaceuticals. Based on type, the global nanoparticles in biotechnology and pharmaceuticals market is segmented into fullerenes, liquid crystals (LC), liposomes (Lipo), nanoshells (NS), quantum dots (QD), superparamagnetic nanoparticles (SPNPs), and others. Fullerenes are among the most commonly used types of nanoparticle owing to their unique physicochemical properties that make them suitable for various biomedical applications. By application type; the global market is segmented into drug delivery systems & therapeutics development; diagnostics & biomarkers development; medical devices development; tissue engineering scaffolds fabrication; food fortification & nutraceutical additives production etc.
Product Definition:
Nanoparticles are particles with at least one dimension measuring less than 100 nm. Nanoparticles have found use in a number of biomedical applications, including drug delivery, imaging, and biosensing. The small size and surface area-to-volume ratio of nanoparticles renders them particularly effective at crossing biological barriers and transporting drugs or other cargo to target tissues.
Fullerenes:
Fullerenes are carbon-rich, hollow polymers. They were first discovered infullerene (Latin for "fuller than"). Fullerene is also called as the allotrope of carbon because it is the only element on Earth that has a full set of sixcarbon rings. It is a versatile material and can be used in applications ranging from automotive parts to industrial filters.
Liquid Crystals:
Liquid crystals are a special type of matter that can be switched on and off. They consist of a solid matrix, which is made up of long chains called polymers. These polymers are filled with colorless liquid crystals, hence the name. Liquid crystal molecules (LCM) align themselves in three dimensions along the length of these polymer chains to form images; this gives them the ability to switch between two states: solid and liquid.
Application Insights:
The biotechnology segment dominated the global market in terms of revenue share in 2017. The pharmaceutical application is expected to witness the fastest growth over the forecast period owing to increasing product usage as imaging agents, drug delivery systems, and nanodiagnostics.
Global nanoparticles in biotechnology.
Pharmaceutical applications accounted for a significant share of nanoparticles based products demand owing to their rising use as drug delivery systems and imaging agents. Moreover, growing R&D activities pertaining to targeted cancer therapies through harnessing the power of Nanoparticle technologies is further anticipated to propel growth over next eight years.
Regional Analysis:
North America dominated the global market in 2017. The growth of this region can be attributed to the presence of a large number of pharmaceutical and biotechnology companies involved in drug discovery and development. Moreover, increasing R&D activities by various organizations is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments by governments for promoting medical tourism, improving healthcare infrastructure, and growing demand for generic drugs due to low prices offered by local manufacturers are some factors driving this regional market. In addition, increasing prevalence of chronic diseases such as cancer & diabetes will boost product demand during nanomedicine application research aimed at developing novel therapies with improved efficacy & efficiency compared to existing therapeutics.
Growth Factors:
- Increasing demand for nanoparticles in biotechnology and pharmaceuticals market due to their unique properties such as high surface area to volume ratio, tunable size, shape and surface chemistry.
- Rising research and development expenditure by the key players for the development of novel applications of nanoparticles in biotechnology and pharmaceuticals market.
- Growing number of collaborations between the key players for the development and commercialization of novel products containing nanoparticles in biotechnology and pharmaceuticals market.
- Proliferation of nanotechnology-based products across different application segments owing to its superior performance over traditional materials used in these applications segments is expected to fuel the growth of nanoparticles in biotechnology and pharmaceuticals market during forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Nanoparticles in Biotechnology and Pharmaceuticals Market Research Report
By Type
Fullerenes, Liquid Crystals, Liposomes, Nanoshells, Quantum dots, Superparamagnetic nanoparticles
By Application
Biotechnology, Pharmaceutical
By Companies
Roche, GE Healthcare, Merck, Novartis, AMAG Pharmaceuticals, Amgen, Bausch & Lomb, Biogen, Celgene, Gilead, Ipsen, Leadiant Biosciences, nanoComposix, Pacira Pharmaceuticals, Pfizer, Shire
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Nanoparticles in Biotechnology and Pharmaceuticals Market Report Segments:
The global Nanoparticles in Biotechnology and Pharmaceuticals market is segmented on the basis of:
Types
Fullerenes, Liquid Crystals, Liposomes, Nanoshells, Quantum dots, Superparamagnetic nanoparticles
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biotechnology, Pharmaceutical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- GE Healthcare
- Merck
- Novartis
- AMAG Pharmaceuticals
- Amgen
- Bausch & Lomb
- Biogen
- Celgene
- Gilead
- Ipsen
- Leadiant Biosciences
- nanoComposix
- Pacira Pharmaceuticals
- Pfizer
- Shire
Highlights of The Nanoparticles in Biotechnology and Pharmaceuticals Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fullerenes
- Liquid Crystals
- Liposomes
- Nanoshells
- Quantum dots
- Superparamagnetic nanoparticles
- By Application:
- Biotechnology
- Pharmaceutical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nanoparticles in Biotechnology and Pharmaceuticals Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nanoparticles are particles that are smaller than 100 nanometers in size. They can be found in a variety of biotechnology and pharmaceuticals applications, including drug delivery, imaging, and diagnostics. Nanoparticles have unique properties that make them useful for these applications, such as their ability to penetrate cells and reach specific locations within them.
Some of the key players operating in the nanoparticles in biotechnology and pharmaceuticals market are Roche, GE Healthcare, Merck, Novartis, AMAG Pharmaceuticals, Amgen, Bausch & Lomb, Biogen, Celgene, Gilead, Ipsen, Leadiant Biosciences, nanoComposix, Pacira Pharmaceuticals, Pfizer, Shire.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nanoparticles in Biotechnology and Pharmaceuticals Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nanoparticles in Biotechnology and Pharmaceuticals Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nanoparticles in Biotechnology and Pharmaceuticals Market - Supply Chain
4.5. Global Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast
4.5.1. Nanoparticles in Biotechnology and Pharmaceuticals Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nanoparticles in Biotechnology and Pharmaceuticals Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nanoparticles in Biotechnology and Pharmaceuticals Market Absolute $ Opportunity
5. Global Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Type
5.3.1. Fullerenes
5.3.2. Liquid Crystals
5.3.3. Liposomes
5.3.4. Nanoshells
5.3.5. Quantum dots
5.3.6. Superparamagnetic nanoparticles
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Application
6.3.1. Biotechnology
6.3.2. Pharmaceutical
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nanoparticles in Biotechnology and Pharmaceuticals Demand Share Forecast, 2019-2029
9. North America Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Application
9.4.1. Biotechnology
9.4.2. Pharmaceutical
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Type
9.7.1. Fullerenes
9.7.2. Liquid Crystals
9.7.3. Liposomes
9.7.4. Nanoshells
9.7.5. Quantum dots
9.7.6. Superparamagnetic nanoparticles
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nanoparticles in Biotechnology and Pharmaceuticals Demand Share Forecast, 2019-2029
10. Latin America Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Application
10.4.1. Biotechnology
10.4.2. Pharmaceutical
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Type
10.7.1. Fullerenes
10.7.2. Liquid Crystals
10.7.3. Liposomes
10.7.4. Nanoshells
10.7.5. Quantum dots
10.7.6. Superparamagnetic nanoparticles
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nanoparticles in Biotechnology and Pharmaceuticals Demand Share Forecast, 2019-2029
11. Europe Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Application
11.4.1. Biotechnology
11.4.2. Pharmaceutical
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Type
11.7.1. Fullerenes
11.7.2. Liquid Crystals
11.7.3. Liposomes
11.7.4. Nanoshells
11.7.5. Quantum dots
11.7.6. Superparamagnetic nanoparticles
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nanoparticles in Biotechnology and Pharmaceuticals Demand Share, 2019-2029
12. Asia Pacific Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Application
12.4.1. Biotechnology
12.4.2. Pharmaceutical
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Type
12.7.1. Fullerenes
12.7.2. Liquid Crystals
12.7.3. Liposomes
12.7.4. Nanoshells
12.7.5. Quantum dots
12.7.6. Superparamagnetic nanoparticles
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nanoparticles in Biotechnology and Pharmaceuticals Demand Share, 2019-2029
13. Middle East & Africa Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Application
13.4.1. Biotechnology
13.4.2. Pharmaceutical
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Volume Forecast by Type
13.7.1. Fullerenes
13.7.2. Liquid Crystals
13.7.3. Liposomes
13.7.4. Nanoshells
13.7.5. Quantum dots
13.7.6. Superparamagnetic nanoparticles
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nanoparticles in Biotechnology and Pharmaceuticals Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Nanoparticles in Biotechnology and Pharmaceuticals Market: Market Share Analysis
14.2. Nanoparticles in Biotechnology and Pharmaceuticals Distributors and Customers
14.3. Nanoparticles in Biotechnology and Pharmaceuticals Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. GE Healthcare
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novartis
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. AMAG Pharmaceuticals
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Amgen
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bausch & Lomb
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Biogen
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Celgene
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Gilead
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Ipsen
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Leadiant Biosciences
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. nanoComposix
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Pacira Pharmaceuticals
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Pfizer
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Shire
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
